Damage to endothelial barriers and its contribution to long COVID

Xiaoming Wu1, Mengqi Xiang1, Haijiao Jing1

  • 1Department of Hematology, The First Hospital, Harbin Medical University, 150001, Harbin, China.

Angiogenesis
|April 27, 2023
PubMed

Insights

Endothelial injury and dysfunction are key drivers of severe COVID-19 and long COVID. This review explores how damage to endothelial barriers in various organs contributes to persistent symptoms after SARS-CoV-2 infection.

Area of Science:

  • Cardiovascular Biology
  • Infectious Diseases
  • Pathology

Background:

  • COVID-19, caused by SARS-CoV-2, presents ongoing global health challenges, exacerbated by emerging viral variants.
  • A significant portion of individuals recovering from acute infection develop persistent symptoms, termed long COVID.
  • Endothelial injury and dysfunction are consistently observed in both acute COVID-19 and convalescent patients across multiple study types.

Purpose of the Study:

  • To elucidate the role of endothelial barriers in the pathogenesis of long COVID.
  • To highlight the knowledge gap concerning organ-specific endothelial barrier damage and its sequelae.
  • To review the mechanisms of endothelial injury and dysfunction in the context of SARS-CoV-2 infection.

Main Methods:

  • Review of clinical, autopsy, animal, and in vitro studies.
  • Analysis of the structural and functional changes in endothelial cells and barriers.
  • Focus on the impact of endothelial barrier damage on different organ systems.

Main Results:

  • Endothelial injury manifests as increased permeability, glycocalyx shedding, and barrier disruption.
  • During acute SARS-CoV-2 infection, endothelial damage leads to microthrombi and multiple organ dysfunction.
  • Persistent endothelial dysfunction in convalescence is a significant contributor to long COVID development.

Conclusions:

  • Endothelial barriers play a critical role in the diverse manifestations of long COVID.
  • Understanding organ-specific endothelial dysfunction is crucial for addressing long COVID.
  • Targeting endothelial injury pathways may offer therapeutic strategies for long COVID recovery.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
18
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
39
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs but also impacts other areas, such as the arms, thereby impairing overall circulation and organ function.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty deposits inside the arterial...
12
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.9K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
13
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
19